X-Cell Medical, Inc. Completes Enrollment For Clinical Trial Of ETHOS II Estradiol Eluting Stent

PRINCETON, N.J.--(BUSINESS WIRE)--May 16, 2006--X-Cell Medical, Inc. announced today that the Company has completed enrollment in its ETHOS II multinational clinical trial to study the safety and effectiveness of the ETHOS Coronary Stent System.